148 related articles for article (PubMed ID: 17506778)
1. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
Fornasini G; Upton RN; Evans AM
Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
3. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of L-carnitine.
Evans AM; Fornasini G
Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
[TBL] [Abstract][Full Text] [Related]
5. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
6. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
7. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease.
Reuter SE; Evans AM; Faull RJ; Chace DH; Fornasini G
Ann Clin Biochem; 2005 Sep; 42(Pt 5):387-93. PubMed ID: 16168195
[TBL] [Abstract][Full Text] [Related]
8. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Reuter SE; Faull RJ; Evans AM
Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis.
Vernez L; Dickenmann M; Steiger J; Wenk M; Krähenbühl S
Nephrol Dial Transplant; 2006 Feb; 21(2):450-8. PubMed ID: 16286428
[TBL] [Abstract][Full Text] [Related]
10. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
[TBL] [Abstract][Full Text] [Related]
11. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
[TBL] [Abstract][Full Text] [Related]
12. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients.
Duranay M; Akay H; Yilmaz FM; Senes M; Tekeli N; Yücel D
Nephrol Dial Transplant; 2006 Nov; 21(11):3211-4. PubMed ID: 16861734
[TBL] [Abstract][Full Text] [Related]
13. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of nocturnal haemodialysis on carnitine metabolism.
Hothi DK; Geary DF; Fisher L; Chan CT
Nephrol Dial Transplant; 2006 Sep; 21(9):2637-41. PubMed ID: 16822785
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of carnitine loss during haemodialysis and haemofiltration.
Rumpf KW; Leschke M; Eisenhauer T; Becker K; Köthe U; Scheler F
Proc Eur Dial Transplant Assoc; 1983; 19():298-301. PubMed ID: 6878244
[TBL] [Abstract][Full Text] [Related]
16. Carnitine deficiency induced during intermittent haemodialysis for renal failure.
Bohmer T; Bergrem H; Eiklid K
Lancet; 1978 Jan; 1(8056):126-8. PubMed ID: 87556
[TBL] [Abstract][Full Text] [Related]
17. [L-carnitine in peritoneal dialysis].
De Vecchi AF; Arduini A; Di Liberato L; Bonomini M
G Ital Nefrol; 2011; 28(4):393-400. PubMed ID: 21809308
[TBL] [Abstract][Full Text] [Related]
18. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
[TBL] [Abstract][Full Text] [Related]
19. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
